1. WHO. Global tuberculosis control: epidemiology, strategy, financing: WHO Report 2009. WHO/HTM/TB/2009.411. WHO, Geneva, Switzerland, 1–303 (2009).
2. WHO. The WHO/IUATLD Project on Anti-tuberculosis Drug Resistance Surveillance, 2002–2007. WHO/HTM/TB/2008.394. WHO, Geneva, Switzerland, 1–142 (2008).
3. DIN 58943–58948; Medical microbiology – diagnosis of tuberculosis – Part 8: methods for the determination of susceptibility of tubercle bacilli to chemotherapeutic agents. DIN: 58943–58948 (2009).
4. US Standard from the National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24-A, NCCLS, Wayne, IN, USA.
5. Heifets LB. Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. CRC Press, Boca Raton, FL, USA (1991).